Back to top

Tale of the Tape

Zacks Equity Research

Immune Design (IMDZ) Worth a Look: Stock Up 5% in Session
November 07, 2016

IMDZ INFI

Trades from $3

Immune Design Corp. (IMDZ - Free Report) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 39.8% in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Immune Design currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

IMMUNE DESIGN Price

 

A better-ranked stock in the same industry is Infinity Pharmaceuticals, Inc. (INFI - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is IMDZ going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

IMMUNE DESIGN (IMDZ) - free report >>

INFINITY PHARMA (INFI) - free report >>